Repligen/$RGEN
About Repligen
Ticker
Industry
Employees
Repligen Metrics
$8.9B
-
-$0.04
0.96
-
Price and volume
Market cap
$8.9B
Beta
0.96
52-week high
$211.13
52-week low
$113.50
Average daily volume
469K
Financial strength
Current ratio
10.442
Quick ratio
8.425
Long term debt to equity
32.742
Total debt to equity
37.398
Interest coverage (TTM)
1.20%
Management effectiveness
Return on assets (TTM)
0.60%
Return on equity (TTM)
-0.40%
Valuation
Price to revenue (TTM)
13.835
Price to book
4.4
Price to tangible book (TTM)
13.69
Price to free cash flow (TTM)
67.449
Growth
Revenue change (TTM)
-4.46%
Earnings per share change (TTM)
-101.86%
3-year revenue growth (CAGR)
2.59%
3-year earnings per share growth (CAGR)
-73.79%
What the Analysts think about Repligen
Analyst Ratings
Repligen Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Repligen Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Repligen News
FAQs
What’s the current market cap for Repligen stock?
What is the P/E ratio for Repligen stock?
Does Repligen stock pay dividends?
No, Repligen (RGEN) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Repligen dividend payment date?
Repligen (RGEN) stock does not pay dividends to its shareholders.
What is the beta indicator for Repligen?
Repligen (RGEN) has a beta rating of 0.96. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.